the board of directors of Eli Lilly and Company (NYSE: LLY) approved a new $15 billion share repurchase program. The company's prior $5 billion share repurchase program was completed in ...
In the fourth quarter of 2024, Eli Lilly and Company (NYSE:LLY) experienced a 45% surge in revenue, reaching $13.53 billion, fueled by strong sales from Mounjaro and Zepbound. Earnings per ...
The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.
Eli Lilly’s profit doubled in the fourth quarter as the Indianapolis ... Evercore ISI analyst Umer Raffat wrote in a note ...
Eli Lilly forecast annual profit largely above Wall Street estimates on Thursday, banking on the launch of its popular ...
Here is what the firm has to say: “Eli Lilly and Company (NYSE:LLY) contributed to performance in the fourth quarter. While shares underperformed, our underweight position versus the benchmark ...
If you want to know who really controls Eli Lilly and Company (NYSE:LLY), then you'll have to look at the makeup of its share registry. With 87% stake, institutions possess the maximum ...